Skip to content
Recall Observatory FDA recall evidence

Drug product

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01

D-0851-2021

August 23, 2021

Class II

Product summary

Firm
Viatris
Event
Event 88542
Status
Terminated
Classification
Class II
Quantity
9,515 bottles
Official record key
drug-enforcement:D-0851-2021

Official wording

Reason: Failed Dissolution Specifications

Code information: Lot #: DN5396, EP9726, EK2417, Exp. Date August 2022

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications